Scarica l'app Stockscreener
5.18
0.77%
-0.04
Pre-mercato:
5.25
0.07
+1.35%
Tevogen Bio Holdings Inc Borsa (TVGN) Ultime notizie
Tevogen Bio Holdings Inc. Files Form 8-K on NASDAQ: Company Details and Key Information for March 2026 - Minichart
Tevogen Bio Regains Nasdaq Compliance After Reverse Split - TipRanks
Tevogen Bio regains Nasdaq compliance following reverse stock split - Investing.com
Tevogen Bio Holdings regains Nasdaq bid-price compliance after 1-for-50 reverse split - TradingView
Nasdaq restores TVGN listing after 1-for-50 reverse split (TVGN) - Stock Titan
Tevogen Bio (TVGN) restores Nasdaq bid-price compliance after 1-for-50 reverse split - Stock Titan
Tevogen Regains Compliance with Nasdaq Minimum Bid Price Requirement - Bitget
Tevogen regains compliance with Nasdaq minimum bid price requirement - TipRanks
Tevogen Bio Regains Compliance With Nasdaq Listing Rule - marketscreener.com
Tevogen Bio Holdings Regains Compliance with Nasdaq Listing Requirements - Quiver Quantitative
Tevogen clears Nasdaq's $1 stock-price rule, keeps listing - Stock Titan
Tevogen Bio Holdings Inc expected to post a loss of $2.00 a shareEarnings Preview - TradingView
Market Pulse: Why is Tevogen Bio Holdings Inc Equity Warrant stock going upWeekly Profit Analysis & Reliable Breakout Forecasts - baoquankhu1.vn
Revenue Check: Why is Tevogen Bio Holdings Inc Equity Warrant stock going up - baoquankhu1.vn
TVGN Technical Analysis & Stock Price Forecast - Intellectia AI
Tevogen Bio Holdings Inc. Announces CIO Mittul Mehta to Speak at Microsoft Fabric Community Conference 2026 on Data Engineering and AI - Quiver Quantitative
Tevogen CIO and Head of Tevogen.AI Mittul Mehta to Speak at Microsoft Fabric Community Conference (FabCon 2026) - Finviz
Tevogen CIO and Head of Tevogen.AI Mittul Mehta to Speak at Microsoft Fabric Community ... - Caledonian Record
Microsoft FabCon puts Tevogen AI chief on two data engineering panels - Stock Titan
Neal Flomenberg sells Tevogen Bio Holdings (TVGN) shares for $6.6k - Investing.com
Tevogen Bio (TVGN) officer sells 972 shares to cover tax obligations - Stock Titan
Tevogen reports performance advancements for Tevogen.AI platform - TipRanks
Tevogen Reaffirms Capital Discipline as Lead Investor Maintains Holdings and Company Limits Share Utilization - The Globe and Mail
Tevogen Bio Advances AI Drug Development Platform with Improved Predictive Accuracy for Target Identification - Quiver Quantitative
Tevogen.AI Reports Advancements in PredicTcell™ Beta, Demonstrates Improved Precision Metrics ... - Bluefield Daily Telegraph
Tevogen.AI Reports Advancements in PredicTcell™ Beta, Demonstrates Improved Precision Metrics and Expands Proprietary AI Infrastructure - The Manila Times
Tevogen.AI Reports Advancements in PredicTcell Beta, Demonstrates Improved Precision Metrics and Expands Proprietary AI Infrastructure - 富途牛牛
Tevogen CEO Dr. Ryan Saadi Reaffirms Clinical Commitment During International Long COVID Awareness Month; Highlights Synergies of New Leadership Team and Digital Care Platform - Finviz
Wall Street Recap: Is Tevogen Bio Holdings Inc Equity Warrant undervalued by DCF analysisEarnings Overview Report & Real-Time Market Trend Scan - baoquankhu1.vn
Tevogen Bio Holdings Inc. is considering the acquisition of Sciometrix and Clinicus platforms to enhance its monitoring capabilities for Long Covid. - Bitget
Tevogen Bio Accelerates Development of TVGN 489 for Long COVID with New Leadership and Strategic Initiatives - Quiver Quantitative
Long COVID ‘clinical emergency’: Tevogen develops T-cell therapy for 65% of U.S. - Stock Titan
Tevogen CEO Dr. Ryan Saadi Reaffirms Clinical Commitment - GlobeNewswire
Tevogen Bio Holdings Inc Share Price USD0.0001 - Hargreaves Lansdown
Tevogen appoints interim leaders across core business verticals - TipRanks
Tevogen Bio Holdings Inc. Appoints Interim Leaders to Drive Diversified Growth Strategy - Quiver Quantitative
Tevogen Names Leadership Team to Execute Diversified Growth Strategy - GlobeNewswire
Free cash flow of Tevogen Bio Holdings Inc. – FWB:G280 - TradingView
Total liabilities & shareholders' equities of Tevogen Bio Holdings Inc. – FWB:G280 - TradingView
Total debt of Tevogen Bio Holdings Inc. – FWB:G280 - TradingView
Tevogen Bio Holdings Inc. Cash Flow – FWB:G280 - TradingView
Tevogen Bio Holdings Inc. Balance Sheet – FWB:G280 - TradingView
Total common shares outstanding of Tevogen Bio Holdings Inc. – FWB:G280 - TradingView
Operating income of Tevogen Bio Holdings Inc. – FWB:G280 - TradingView
Price to book ratio of Tevogen Bio Holdings Inc. – FWB:G280 - TradingView
Price to sales ratio of Tevogen Bio Holdings Inc. – FWB:G280 - TradingView
Total operating expenses of Tevogen Bio Holdings Inc. – FWB:G280 - TradingView
After tax other income/expense of Tevogen Bio Holdings Inc. – FWB:G280 - TradingView
Net current asset value per share of Tevogen Bio Holdings Inc. – FWB:G280 - TradingView
Enterprise value to EBITDA ratio of Tevogen Bio Holdings Inc. – FWB:G280 - TradingView
Diluted earnings per share (diluted EPS) of Tevogen Bio Holdings Inc. – FWB:G280 - TradingView
Price to cash flow ratio of Tevogen Bio Holdings Inc. – FWB:G280 - TradingView
Non-controlling/minority interest of Tevogen Bio Holdings Inc. – FWB:G280 - TradingView
Gross profit of Tevogen Bio Holdings Inc. – FWB:G280 - TradingView
Diluted net income available to common stockholders of Tevogen Bio Holdings Inc. – FWB:G280 - TradingView
Free cash flow of Tevogen Bio Holdings Inc. – TRADEGATE:G280 - TradingView
Discontinued operations of Tevogen Bio Holdings Inc. – TRADEGATE:G280 - TradingView
Operating income of Tevogen Bio Holdings Inc. – TRADEGATE:G280 - TradingView
Operating expenses (excl. COGS) of Tevogen Bio Holdings Inc. – TRADEGATE:G280 - TradingView
Total operating expenses of Tevogen Bio Holdings Inc. – TRADEGATE:G280 - TradingView
Total revenue of Tevogen Bio Holdings Inc. – TRADEGATE:G280 - TradingView
EBITDA of Tevogen Bio Holdings Inc. – TRADEGATE:G280 - TradingView
Non-controlling/minority interest of Tevogen Bio Holdings Inc. – TRADEGATE:G280 - TradingView
After tax other income/expense of Tevogen Bio Holdings Inc. – TRADEGATE:G280 - TradingView
Tevogen Bio Holdings Inc. Statistics – FWB:G280 - TradingView
Number of employees of Tevogen Bio Holdings Inc. – FWB:G280 - TradingView
Tevogen Bio Holdings Inc. Earnings and Revenue – FWB:G280 - TradingView
Tevogen Bio Holdings Inc. Income Statement – FWB:G280 - TradingView
Basic earnings per share (basic EPS) of Tevogen Bio Holdings Inc. – FWB:G280 - TradingView
Market Review: Is Tevogen Bio Holdings Inc Equity Warrant undervalued by DCF analysis - baoquankhu1.vn
1.82%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):